Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127223851 | 12722385 | 1 | I | 201508 | 20160520 | 20160907 | 20160907 | EXP | US-BAYER-2016-103558 | BAYER | 61.00 | YR | A | M | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127223851 | 12722385 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | ||||
| 127223851 | 12722385 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | ||||
| 127223851 | 12722385 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | ||||
| 127223851 | 12722385 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | ||||
| 127223851 | 12722385 | 5 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | 81 MG, QD | Y | 999999 | 81 | MG | TABLET | QD | |||||
| 127223851 | 12722385 | 6 | SS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | UNK | Y | 999999 | TABLET | |||||||||
| 127223851 | 12722385 | 7 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 75 MG, UNK | 0 | 75 | MG | |||||||||
| 127223851 | 12722385 | 8 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 127223851 | 12722385 | 9 | SS | TICAGRELOR | TICAGRELOR | 1 | 90 MG, UNK | 0 | 90 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127223851 | 12722385 | 1 | Atrial fibrillation |
| 127223851 | 12722385 | 2 | Thrombosis prophylaxis |
| 127223851 | 12722385 | 3 | Cerebrovascular accident prophylaxis |
| 127223851 | 12722385 | 4 | Atrial fibrillation |
| 127223851 | 12722385 | 5 | Coronary arterial stent insertion |
| 127223851 | 12722385 | 6 | Coronary arterial stent insertion |
| 127223851 | 12722385 | 7 | Coronary arterial stent insertion |
| 127223851 | 12722385 | 8 | Coronary arterial stent insertion |
| 127223851 | 12722385 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127223851 | 12722385 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127223851 | 12722385 | Lower gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127223851 | 12722385 | 1 | 20141021 | 20150125 | 0 | |
| 127223851 | 12722385 | 2 | 20150727 | 20150926 | 0 | |
| 127223851 | 12722385 | 3 | 20150311 | 20150610 | 0 | |
| 127223851 | 12722385 | 4 | 20151001 | 20151007 | 0 | |
| 127223851 | 12722385 | 5 | 201510 | 0 | ||
| 127223851 | 12722385 | 6 | 20151008 | 0 | ||
| 127223851 | 12722385 | 7 | 201510 | 0 | ||
| 127223851 | 12722385 | 8 | 20151008 | 0 | ||
| 127223851 | 12722385 | 9 | 201510 | 0 |